Medtronic reviews

From the time of Covidien acquisition to May 2021, and amidst the confusion of flailing and drowning in a seeming infinitely layered and chaotic bureaucracy, progress was almost impossible, agility just out of reach and innovation nothing more than a lovely ideal. As Martha confirms, the growth was not commensurate with our position as a leader in the market. QOL outside of Medtronic was greatly diminished by insanely demanding traveling pace and hefty responsibilities. Work-life balance was not possible in the mastery of this role, despite the lip service continually given to the topic. The real culture was: if your personal life did not allow you to devote ALL of your time and effort to MDT and the myriad projects you were involved with simultaneously, there were negative consequences.